Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction

Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial

1999 • 840 citations

1999 Update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations

1999 • 758 citations

Abciximab Facilitates the Rate and Extent of Thrombolysis

1999 • 691 citations

Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial

2001 • 690 citations

Thrombolysis for Acute Myocardial Infarction

1998 • 222 citations

Trial of Abciximab With and Without Low-Dose Reteplase for Acute Myocardial Infarction

2000 • 191 citations

Randomized Comparison of Enoxaparin, a Low-Molecular-Weight Heparin, With Unfractionated Heparin Adjunctive to Recombinant Tissue Plasminogen Activator Thrombolysis and Aspirin

2001 • 175 citations

Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhage

2001 • 68 citations

The low-molecular-weight heparin dalteparin as adjuvant therapy in acute myocardial infarction: The ASSENT PLUS study

2001 • 45 citations

Low-Molecular-Weight Heparins in the Treatment of Acute Coronary Syndromes

2001 • 32 citations

Low Molecular Weight Heparin Versus Unfractionated Heparin Following Thrombolysis in Myocardial Infarction

1998 • 7 citations